Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.96 Insider Own11.81% Shs Outstand44.07M Perf Week-7.36%
Market Cap14.18M Forward P/E- EPS next Y-0.15 Insider Trans6.13% Shs Float39.14M Perf Month-16.12%
Income-86.65M PEG- EPS next Q-0.28 Inst Own57.76% Short Float / Ratio2.59% / 3.03 Perf Quarter-55.67%
Sales14.67M P/S0.97 EPS this Y27.22% Inst Trans2.14% Short Interest1.01M Perf Half Y-68.04%
Book/sh-0.04 P/B- EPS next Y90.08% ROA-86.91% Target Price3.00 Perf Year-92.28%
Cash/sh0.89 P/C0.36 EPS next 5Y- ROE-225.93% 52W Range0.21 - 3.96 Perf YTD-72.92%
Dividend- P/FCF- EPS past 5Y13.71% ROI-221.43% 52W High-91.93% Beta2.08
Dividend %- Quick Ratio3.24 Sales past 5Y2.21% Gross Margin92.81% 52W Low52.19% ATR0.05
Employees56 Current Ratio3.31 Sales Q/Q-20.25% Oper. Margin-570.32% RSI (14)47.39 Volatility12.93% 17.04%
OptionableYes Debt/Eq- EPS Q/Q33.96% Profit Margin-590.80% Rel Volume0.00 Prev Close0.32
ShortableYes LT Debt/Eq- EarningsNov 09 AMC Payout- Avg Volume334.22K Price0.32
Recom1.33 SMA20-6.07% SMA503.54% SMA200-59.50% Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jun-26-19Initiated Citigroup Buy $22
Jan-29-19Initiated Robert W. Baird Outperform $47
May-09-18Initiated B. Riley FBR, Inc. Buy $24
Jan-03-18Initiated Ladenburg Thalmann Buy $32
Oct-19-17Initiated ROTH Capital Buy $35
Jun-21-17Resumed Wedbush Outperform $28 → $34
Nov-09-23 04:36PM
Sep-12-23 04:27PM
04:05PM Loading…
Sep-05-23 04:05PM
Aug-14-23 07:31PM
Jul-06-23 03:30PM
Jun-29-23 08:00AM
Jun-28-23 04:05PM
Jun-27-23 08:08AM
May-31-23 07:25AM
May-11-23 04:07PM
04:00PM Loading…
May-04-23 06:49AM
May-03-23 04:05PM
Apr-13-23 08:00AM
Mar-31-23 06:17AM
Mar-18-23 08:40AM
Mar-16-23 04:28PM
Feb-09-23 12:32PM
Feb-08-23 05:00PM
Jan-18-23 01:58PM
Dec-29-22 05:15AM
Dec-28-22 06:58AM
Dec-20-22 05:02AM
Dec-15-22 05:45PM
Dec-08-22 08:00AM
04:05PM Loading…
Dec-07-22 04:05PM
Nov-09-22 06:15AM
Nov-08-22 04:05PM
Nov-03-22 05:55PM
Oct-30-22 09:00AM
Oct-25-22 07:09AM
Oct-24-22 04:05PM
Oct-11-22 08:00AM
Oct-06-22 09:40AM
Oct-05-22 09:53AM
Sep-28-22 06:41AM
Sep-22-22 08:00AM
Sep-06-22 09:16AM
Sep-01-22 08:00AM
Aug-04-22 07:25PM
Jul-28-22 08:00AM
Jul-20-22 08:00AM
Jul-18-22 08:00AM
Jul-06-22 09:40AM
Jun-27-22 04:05PM
Jun-13-22 08:00AM
Jun-08-22 08:00AM
Jun-07-22 04:05PM
Jun-03-22 08:00AM
May-20-22 03:14PM
May-12-22 06:25AM
May-10-22 04:30PM
May-07-22 10:55AM
May-05-22 07:25PM
Apr-29-22 06:00PM
Apr-25-22 08:00AM
Apr-21-22 04:05PM
Apr-18-22 08:00AM
Mar-17-22 09:37AM
Mar-16-22 10:23PM
Mar-15-22 02:42PM
Mar-10-22 04:01PM
Feb-24-22 04:05PM
Feb-14-22 06:30AM
Jan-20-22 01:38PM
Jan-06-22 08:00AM
Jan-03-22 08:00AM
Dec-23-21 08:16AM
Dec-21-21 04:10PM
Dec-20-21 04:15PM
Dec-16-21 06:32AM
Dec-15-21 08:00AM
Dec-01-21 08:00AM
Nov-10-21 08:00AM
Nov-04-21 06:25PM
Nov-02-21 04:05PM
Nov-01-21 08:00AM
Oct-21-21 04:05PM
Oct-17-21 10:48AM
Oct-01-21 04:05PM
Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KAYNE RICHARD A10% OwnerNov 02Buy0.3023,3986,9665,375,225Nov 02 09:21 PM
KAYNE RICHARD A10% OwnerNov 01Buy0.28100,00027,9705,351,827Nov 02 09:21 PM
KAYNE RICHARD A10% OwnerOct 31Buy0.24154,84137,8805,251,827Nov 02 09:21 PM
KAWAS LEEN10% OwnerOct 31Buy0.2624,3326,3754,391,432Nov 02 09:14 PM
Mayer Eldon C. IIIEx VP & Chief Commerc. OfficerMar 17Sale1.074,3954,70456,073Mar 21 09:00 PM
Dietz Thomas JohnDirectorJan 23Buy1.4350,00071,58050,000Jan 25 08:54 PM
Murray ChristineDirectorDec 29Sale1.225,0006,10411,000Jan 03 08:30 PM
Glenn Jeffrey SDirectorDec 22Buy1.28100,000127,950182,355Dec 27 05:31 PM
Dietz Thomas JohnDirectorDec 22Sale1.1722,50026,30221,000Dec 27 05:31 PM